INDV (Indivior Pharmaceuticals) Float Percentage Of Total Shares Outstanding: 84.18% (As of Jun. 28, 2026)


INDV Indivior Pharmaceuticals Inc INDV
69 GF Score
Price $41.82
GF Value $22.98
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Indivior Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Indivior Pharmaceuticals INDV +1.31% 69 Float Percentage Of Total Shares Outstanding is 84.18% as of Jun. 28, 2026. GuruFocus rates INDV with a GF Score™ of 69/100 and a GF Value™ of $22.98 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Indivior Pharmaceuticals's float shares is 99.50 Mil. Indivior Pharmaceuticals's total shares outstanding is 118.20 Mil. Indivior Pharmaceuticals's float percentage of total shares outstanding is 84.18%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Indivior Pharmaceuticals's Insider Ownership is 2.14%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Indivior Pharmaceuticals's Institutional Ownership is 109.30%.

INDV
69GF Score
Indivior Pharmaceuticals Inc INDV
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indivior Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Indivior Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=99.50/118.20
=84.18%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 84.18% mean?
Indivior Pharmaceuticals (INDV) has a Float Percentage Of Total Shares Outstanding of 84.18% as of Jun. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Indivior Pharmaceuticals and its competitors.
Is Indivior Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
Indivior Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 84.18%. Overall, Indivior Pharmaceuticals has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Indivior Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to AMRX and KNSA?
Indivior Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 84.18% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Indivior Pharmaceuticals and its competitors. Indivior Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 84.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indivior Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Indivior Pharmaceuticals (INDV) is currently considered Significantly Overvalued. The stock's GF Value™ is $22.98, compared to a current price of $41.82 — trading 82% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 84.18%. Indivior Pharmaceuticals' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Indivior Pharmaceuticals (INDV), the current Float Percentage Of Total Shares Outstanding is 84.18% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indivior Pharmaceuticals (INDV) Overvalued in 2026?

Based on GuruFocus' analysis, Indivior Pharmaceuticals stock appears to be overvalued. The current stock price of $41.82 is trading 82% above its estimated GF Value™ of $22.98. GuruFocus considers Indivior Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for INDV:

  • Float Percentage Of Total Shares Outstanding: 84.18%
  • GF Value™: $22.98 vs. price of $41.82 (82% above fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the INDV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indivior Pharmaceuticals Business Description

Other Exchanges E7P:Germany
Address 10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
69GF Score

Get the complete analysis for INDV

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.82
Price
$22.98
GF Value